Vanguard Capital Management
ATYR

Vanguard Capital Management’s aTyr Pharma ATYR Stock Holding History

Vanguard Capital Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27M Sell
3,808,091
-4,041
-0.1% -$2.64K ﹤0.01% 3382
2026
Q1 		$2.97M Buy
+3,812,132
New +$3.22M ﹤0.01% 3239

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $140M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management's ATYR Position: Q2 2026 in Review

Vanguard Capital Management reduced its aTyr Pharma (ATYR) stake by 0.11% in Q2 2026, selling an estimated $2.64K and leaving 3,808,091 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #3382.

Vanguard Capital Management first reported a position in ATYR in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.97M in Q1 2026. 86 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Vanguard Capital Management held 3,808,091 shares of aTyr Pharma worth $2.27M as of Q2 2026.
  • Vanguard Capital Management sold 4,041 aTyr Pharma shares in Q2 2026, an estimated $2.64K.
  • aTyr Pharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3382 holding.
  • Vanguard Capital Management first reported a position in aTyr Pharma in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's aTyr Pharma position peaked at $2.97M in Q1 2026.
  • 86 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.